share_log

Aslan Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-K2 HealthVentures Equity Trust LLC(6.2%),Parag Shah(6.2%), etc.

Aslan Pharmaceuticals | SC 13G:超過5%持股股東披露文件-K2 HealthVentures Equity Trust LLC(6.2%),Parag Shah(6.2%)等

美股sec公告 ·  2023/03/20 17:20
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息